Dare Bioscience, Inc. Cash and Restricted Cash
Dare Bioscience, Inc. (DARE) had Cash and Restricted Cash of $12.92 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12.92M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.82M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $25.01M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $23.38M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $12.92M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $18.82M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $25.01M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $23.38M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $5.34M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $10.63M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $16.00M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $11.53M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $16.71M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $3.97M 10-Q · filed 2025-05-13 |
| 2023-12-31 | $10.81M 10-K · filed 2026-03-26 |
| 2023-09-30 | $14.23M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $13.66M 10-Q · filed 2024-08-12 |
| 2023-03-31 | $19.83M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $34.67M 10-K · filed 2025-03-31 |
| 2022-09-30 | $40.39M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $32.07M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $39.32M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $51.67M 10-K · filed 2024-03-28 |
| 2021-09-30 | $45.57M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $9.11M 10-Q · filed 2022-08-09 |
| 2021-03-31 | $7.66M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $4.67M 10-K · filed 2023-03-30 |
| 2020-09-30 | $5.39M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $5.35M 10-Q · filed 2021-08-12 |
| 2020-03-31 | $5.05M 10-Q · filed 2021-05-13 |
| 2019-12-31 | $4.78M 10-K · filed 2022-03-31 |
| 2019-09-30 | $2.44M 10-Q · filed 2020-11-12 |
| 2019-06-30 | $5.63M 10-Q · filed 2020-08-12 |
| 2019-03-31 | $3.51M 10-Q · filed 2020-05-14 |
| 2018-12-31 | $6.81M 10-K · filed 2021-03-30 |
| 2018-09-30 | $9.54M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $12.45M 10-Q · filed 2019-08-14 |
| 2018-03-31 | $15.63M 10-Q · filed 2019-05-14 |
| 2017-12-31 | $7.56M 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |